Drug Delivery Devices Market (2025-2032)
The Drug Delivery Devices Market is projected to reach $24.65 billion by 2032, at a CAGR of 7.6% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 220
- Format
- PDF + Excel
- Report ID
- MRHC - 1041059
- Base year
- 2022
- 2032 · FORECAST
- $24.65B
- 2032
- $24.65B
- CAGR 2025–2032
- 7.6%
2022–2024 baseline · 2025–2032 forecast at 7.6% CAGR · hover a bar for the value
Key highlights
The Drug Delivery Devices Market is projected to reach $24.65 billion by 2032, at a CAGR of 7.6% from 2025 to 2032.
The parenteral drug delivery systems segment is expected to account for the largest share of the market.
The diabetes segment is expected to account for the largest share of the market.
Report summary
| Particulars | Details |
|---|---|
| Page No | ~220 |
| Format | |
| Forecast Period | 2025-2032 |
| Base Year | 2022 |
| CAGR | 7.6% |
| Market Size (Value) | $24.65 billion |
| Market Size (Volume) | NA |
| Segments Covered | Products and Therapeutic Area |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Belgium, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Indonesia, Singapore, Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa (U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa) |
| Key Companies | Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), GMP Laboratories of America, Inc. (U.S.), Gemini Pharmaceuticals, Inc. (U.S.), Resyca GmbH (Netherlands), Novartis International AG (Switzerland), Becton, Dickinson, and Company (U.S.), Lifelong Meditech Private Limited (India), Bright Pharma Caps, Inc. (U.S.), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Eclam Medical ACS Ltd. (Israel), SMC Ltd. (U.S.), Owen Mumford Limited (U.K.), Haseleimer GmbH (Germany), SHL Medical AG (Switzerland), Ypsomed Holding AG (Switzerland), AptarGroup, Inc. (U.S.), Kindeva Drug Delivery L.P. (U.S.), Nemera Group (France), and Recipharm AB (Sweden), |
Report overview
Segments covered: product, therapeutic area. Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Drug delivery devices are storage systems or similar technologies that are used to administer drugs or medicines into the body of a patient through various routes in order to achieve a therapeutic effect.
The growth of the drug delivery devices market is driven by several factors, including the increasing prevalence of chronic diseases, the advancements in disease treatment approaches, growing R&D expenditure in pharmaceutical and biotechnology industries, and increasing demand for advanced drug delivery systems. Factors such as emerging economies and technological advancements in drug delivery systems are a few of the opportunities that would help grow the market in the future. Biocompatibility and acceptability could be considered a challenge for the drug delivery devices market. However, manufacturing defects and a lack of awareness and education about newer drug delivery systems restrain the growth of the market.
Report infographic
Market dynamics
1 factors across 1 forceTechnological Advancements in Drug Delivery Devices
Drug delivery devices are technologies or systems that store drug molecules and accelerate the reach of the drugs to various parts of the body depending on the disease that is being treated. This maximizes the therapeutic efficacy of the drug and minimizes its off-target accumulation in the body. In recent times, there have been a lot of changes and developments in order to provide a convenient, controlled, and targeted delivery of drugs. Furthermore, these changes have led to high efficacy and minimal off-target accumulation of the drug, therefore leading to the launches and approvals of several innovative products. For instance, in December 2022, Biocorp, a subsidiary of Novo Nordisk A/S (Denmark), announced the receival of the FDA 510(k) clearance to market Biocorp’s smart insulin pen device that automatically collects and records key treatment information and transmits it to a digital application. This data includes selected insulin units, date, and the time of injection.
Advanced drug delivery systems allow the patient to receive a tailored or specific amount of dose required, rapid, efficient, and sustained drug delivery, and minimize side effects of drugs. Advanced drug delivery systems and devices have proved to be useful for drug administration and are being suggested to be used as a carrier for novel drugs and also personalized treatment of patients based on the intensity and type of diagnosis or condition.
Several companies are aiming to develop new drug delivery systems in order to introduce new modalities of drugs. For instance, in April 2021, Gerresheimer AG (Germany) collaborated with SensAIR (Sweden) to present an on-body drug delivery device to help patients self-administer medication in a familiar environment such as their homes. This device can be used for drugs that have different viscosities and different requirements. This means that the size of the needle used and variable cartridge sizes can be adjusted through the patient’s smartphone.
Such developments aid the increase in the use of these technologies and increased patient compliance, hence leading to the growth of the market.
Table of contents
10 chapters · 141 sections · 220 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Parenteral Drug Delivery Systems | — |
| By Therapeutic Area | Diabetes | — |
By Product
- The parenteral drug delivery systems segment is expected to account for the largest share of the market.
- Parenteral drug delivery systems are an invasive type of route taken to administer drugs directly into the bloodstream without undergoing first-pass metabolism.
- This can be done through the subcutaneous route, intradermal route, intramuscular route, or intravenous route.
- Pen injectors, syringes, autoinjectors, wearable injectors, needle-free injectors, and transdermal patches are some of the devices that are used to administer drugs through this route.
- The large share of the market is driven by factors such as an effective route for delivering active pharmaceutical substances that may have less bioavailability, a narrow therapeutic index, and faster effectiveness to the required organ.
By Therapeutic Area
- The diabetes segment is expected to account for the largest share of the market.
- Diabetes is a non-communicable and chronic disease that occurs when the body is not able to produce sufficient insulin or cannot use the produced insulin to regulate the sugar a person consumes.
- Various drug delivery devices are used to regulate and track insulin levels in a patient.
- Some of these devices include insulin pumps, insulin pens, wearable glucose monitors, and autoinjectors, among others.
- These devices regulate and track insulin levels and are connected with an application whose access is with the healthcare provider and close family to monitor glucose levels and administer insulin whenever needed.
- This segment is driven by factors such as a large variety of available devices to manage insulin levels, improved patient drug compliance, and less risk of side effects due to uniform administration of drugs.
Competitive landscape
- Koninklijke Philips N.V. · Netherlands
- OMRON Corporation · Japan
- GMP Laboratories of America, Inc. (U.S.)
- Gemini Pharmaceuticals, Inc. (U.S.)
- Resyca GmbH · Netherlands
- Novartis International AG · Switzerland
- Becton
- Dickinson, Company (U.S.)
- Lifelong Meditech Private Limited · India
- Bright Pharma Caps, Inc. (U.S.)
- Gerresheimer AG · Germany
- West Pharmaceutical Services, Inc. (U.S.)
- Eclam Medical ACS Ltd. · Israel
- SMC Ltd. (U.S.)
- Owen Mumford Limited (U.K.)
- Haselmeier GmbH · Germany
- SHL Medical AG · Switzerland
- Ypsomed Holding AG · Switzerland
- AptarGroup, Inc. (U.S.)
- Kindeva Drug Delivery L.P. (U.S.)
- Nemera Group · France
- Recipharm AB · Sweden
Frequently asked questions
This market study covers the market sizes & forecasts of the drug delivery devices based on products, therapeutic areas, and geography. This market study also provides the value analysis of various segments and subsegments of the global drug delivery devices market at country levels.
Cite this report
Meticulous Research. (2025). Drug Delivery Devices Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041059). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/drug-delivery-devices-market-5742